Published in Int J Geriatr Psychiatry on December 01, 2007
Co-occurring depressive symptoms in the older patient with schizophrenia. Drugs Aging (2008) 0.96
Suicide attempts and associated factors in older adults with schizophrenia. Schizophr Res (2010) 0.95
Health-related quality of life in patients with dual diagnosis: clinical correlates. Health Qual Life Outcomes (2012) 0.82
Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia. Neuropsychiatr Dis Treat (2013) 0.80
Suicidal behavior in the older patient with schizophrenia. Aging health (2011) 0.78
Elderly patients with schizophrenia and depression: diagnosis and treatment. Clin Schizophr Relat Psychoses (2011) 0.77
Escape from Discrepancy: Self-Esteem and Quality of Life as Predictors of Current Suicidal Ideation Among Individuals with Schizophrenia. Community Ment Health J (2015) 0.76
Personality traits predicting quality of life and overall functioning in schizophrenia. Schizophr Res (2016) 0.75
Triggers of suicide ideation and protective factors of actually executing suicide among first onset cases in older psychiatric outpatients: a qualitative study. BMC Psychiatry (2014) 0.75
Case-control study of the relationship of functioning to suicide in a community-based sample of individuals with schizophrenia in China. Community Ment Health J (2011) 0.75
Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition. Can J Psychiatry (2017) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89
The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull (1984) 5.69
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry (1996) 3.61
Risk factors for suicide in later life. Biol Psychiatry (2002) 2.58
Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53
Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res (1992) 2.49
Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia. J Clin Psychopharmacol (2002) 2.24
Completed suicide among older patients in primary care practices: a controlled study. J Am Geriatr Soc (2000) 1.95
The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res (2003) 1.58
Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull (1990) 1.52
Psychiatric disorder and personality factors associated with suicide in older people: a descriptive and case-control study. Int J Geriatr Psychiatry (2001) 1.18
Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry (2001) 1.08
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry (2003) 0.96
Depression in chronic schizophrenia. Br J Psychiatry (1983) 0.95
Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res (2001) 0.93
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life? J Clin Psychiatry (1999) 0.89
Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristics. Eur Psychiatry (2005) 0.89
Suicidal indicators in schizophrenia. Acta Psychiatr Scand (1990) 0.83
Psychosis and functioning as risk factors for later suicidal activity among schizophrenia and schizoaffective patients: a disease-based interactive model. Suicide Life Threat Behav (1999) 0.82
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem (2001) 2.47
Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 2.01
Jackknife-based method for measuring LRP onset latency differences. Psychophysiology (1998) 1.98
An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.82
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain (1999) 1.71
Deep hypothermic circulatory arrest: I. Effects of cooling on electroencephalogram and evoked potentials. Ann Thorac Surg (2001) 1.70
Community immunization programme in response to an outbreak of invasive Neisseria meningitidis serogroup C infection in the Trent region of England 1995-1996. J Public Health Med (1997) 1.62
Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics (1999) 1.60
Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor. Thromb Haemost (2004) 1.59
Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. Arch Gen Psychiatry (1994) 1.55
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry (1993) 1.52
Association of beta-endorphin with specific clinical symptoms of depression. Am J Psychiatry (1992) 1.51
Survey of attitudes to testing for human immunodeficiency virus infection in antenatal clinics in West Glamorgan. Br J Obstet Gynaecol (1989) 1.51
Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J Virol (1991) 1.49
A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. J Clin Psychopharmacol (1996) 1.47
The psychological and physical health of hospice caregivers. Ann Clin Psychiatry (2000) 1.44
The walk-in patient as a 'customer': a key dimension in evaluation and treatment. Am J Orthopsychiatry (1972) 1.42
Are patients receiving amiodarone at increased risk for cardiac operations? Ann Thorac Surg (1994) 1.40
Plesiomonas shigelloides--an uncommon cause of diarrhoea in cats? Vet Rec (2000) 1.40
Total phenolic compounds, flavonoids, and radical scavenging activity of 21 selected tropical plants. J Food Sci (2010) 1.35
A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry (1998) 1.33
Expression of the polyomavirus VP2 and VP3 proteins in insect cells: coexpression with the major capsid protein VP1 alters VP2/VP3 subcellular localization. Virology (1993) 1.32
The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc (1995) 1.31
Brain hydatidosis: report on 117 cases. Childs Nerv Syst (2000) 1.29
Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.29
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord (2010) 1.27
Management of negative symptoms among patients with schizophrenia attending multiple-family groups. Psychiatr Serv (2000) 1.27
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study. Antimicrob Agents Chemother (1996) 1.26
Reduction of immune function in life stress and depression. Biol Psychiatry (1990) 1.23
Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry (1991) 1.20
Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry (1992) 1.20
Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry (1998) 1.19
Inbreeding effects on reproductive outcome in a Sudanese population. Hum Hered (1990) 1.16
Deep hypothermic circulatory arrest: II. Changes in electroencephalogram and evoked potentials during rewarming. Ann Thorac Surg (2001) 1.16
Adverse behavioral effects of benzodiazepines. J Fam Pract (1977) 1.16
The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry (1991) 1.15
A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain (1998) 1.15
Unexpectedly large mass loss during the thermal pulse cycle of the red giant star R Sculptoris. Nature (2012) 1.11
Antidepressant drug studies in the elderly. Psychiatr Clin North Am (1988) 1.11
Saccadic system functioning among schizophrenia patients and their first-degree biological relatives. J Abnorm Psychol (1994) 1.09
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. Psychopharmacol Bull (1997) 1.09
Association of depressive symptoms with worse functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry (2001) 1.08
Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis (1998) 1.08
Neurophysiologic effects of retrograde cerebral perfusion used for aortic reconstruction. J Cardiothorac Vasc Anesth (1998) 1.07
Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry (1983) 1.06
Aging and outcome in schizophrenia. Acta Psychiatr Scand (2003) 1.05
Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol Psychiatry (1995) 1.05
Assessing knowledge of cardiovascular health-related diet and exercise behaviors in Anglo- and Mexican-Americans. Prev Med (1987) 1.05
Measuring symptoms of grief and bereavement. Am J Psychiatry (1982) 1.04
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry (1997) 1.03
Treating depressions of bereavement with antidepressants. A pilot study. Psychiatr Clin North Am (1987) 1.03
Vasorelaxation induced by common edible tropical plant extracts in isolated rat aorta and mesenteric vascular bed. J Ethnopharmacol (2004) 1.02
The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Biol Psychiatry (1994) 1.01
Preliminary longitudinal assessment of quality of life in patients with major depression. Psychopharmacol Bull (1997) 1.01
Is late-onset schizophrenia a subtype of schizophrenia? Acta Psychiatr Scand (2010) 1.01
Phylogenetic diversity, polyamine pattern and DNA base composition of members of the order Planctomycetales. Int J Syst Bacteriol (1999) 1.00
Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol (1981) 1.00
Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res (2000) 1.00
The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology (2001) 1.00
Parasitoids of medfly, Ceratitis capitata, and related tephritids in Kenyan coffee: a predominantly koinobiont assemblage. Bull Entomol Res (2000) 0.99
Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry (2000) 0.98
Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J (1991) 0.97
Gender differences in schizophrenia. J Nerv Ment Dis (1995) 0.97
Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res (2001) 0.96
Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial. Arch Intern Med (1988) 0.96
Super viscous silicone liquid in retinal surgery. Aust J Ophthalmol (1982) 0.95
Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? J Neuroimaging (1999) 0.94
Effects of chronic stress on beta-adrenergic receptors in the homeless. Psychosom Med (1994) 0.94
Plasma catecholamine and lymphocyte beta 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosom Med (1997) 0.93
Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res (2001) 0.93
Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychol Med (2011) 0.93
Development of the Texas Inventory of Grief. Am J Psychiatry (1977) 0.93
Detection of low-frequency lambda-doublet transitions of the free 12CH and 13CH radicals. Proc Natl Acad Sci U S A (2006) 0.92
Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol (2006) 0.92
Neuropsychological performance of HIV-1 infected men with major depression. HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1997) 0.92
Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. Am J Psychiatry (2000) 0.92
A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr Scand (2001) 0.92
The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group. Biol Psychiatry (1991) 0.92
Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Eye (Lond) (2005) 0.92
Clinical aspects of grief and bereavement. Prim Care (1979) 0.91
Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder. J Clin Psychiatry (2001) 0.91
An analysis of the skin conductance orienting response in samples of American, British, and German schizophrenics. Biol Psychol (1982) 0.91
Psychiatric morbidity associated with acquired immune deficiency syndrome-related grief resolution. J Nerv Ment Dis (1995) 0.91
Sleep EEG studies during early and late partial sleep deprivation in premenstrual dysphoric disorder and normal control subjects. Psychiatry Res (1999) 0.90
Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology. Can J Cardiol (2009) 0.89
Neutrophilia and lymphopenia in major mood disorders. Psychiatry Res (1988) 0.89
Indwelling umbilical arterial catheter: a preferred sampling site for blood culture. Pediatrics (1988) 0.89
Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry (1999) 0.89
Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers. J Clin Psychopharmacol (1994) 0.88
Depression in the aged. An overview. Psychiatr Clin North Am (1988) 0.88
Polysomnography and depressive symptoms in primary alcoholics with and without a lifetime diagnosis of secondary depression and in patients with primary major depression. J Affect Disord (1999) 0.88
OKT3 first-dose reaction: association with T cell subsets and cytokine release. Kidney Int (1991) 0.88
Putting sexuality (back) into HIV/AIDS: issues, theory and practice. Glob Public Health (2007) 0.88
Brown deposits in the optic of foldable intraocular lenses in patients with uveitis. Eye (Lond) (2004) 0.87
Results of revascularization in patients with severe left ventricular dysfunction. Circulation (1995) 0.87
Vulnerable caregivers of patients with Alzheimer's disease have a deficit in circulating CD62L- T lymphocytes. Psychosom Med (1999) 0.87
Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis. J Chemother (2004) 0.87
Alpha-tocopherol content in 62 edible tropical plants. J Agric Food Chem (2001) 0.87